Resection of the entire first rib for a malignant tumor via the transclavicular approach: a case report and literature review - Top-Institutions - MDSpire

Resection of the entire first rib for a malignant tumor via the transclavicular approach: a case report and literature review

  • By

  • Zhiqing Zhao

  • Xinli Sun

  • Bing Wang

  • Taiqiang Yan

  • March 18, 2026

  • 0 min

Share

Top Institutions in Surgery

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Thoracic Surgery
    • Orthopedic Oncology
    • Surgical Oncology

  • #2

    MD Anderson Cancer Center
    MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Thoracic Surgery
    • Orthopedic Oncology
    • Oncology

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Thoracic Surgery
    • Orthopedic Oncology
    • Surgical Oncology

  • #4

    Johns Hopkins Hospital
    Johns Hopkins Hospital

    Baltimore, MD

    Key Differentiators

    • Thoracic Surgery
    • Orthopedic Oncology

  • #5

    University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical Center

    Dallas, TX

    Key Differentiators

    • Thoracic Surgery
    • Orthopedic Oncology

Original Source(s)

Resection of the entire first rib for a malignant tumor via the transclavicular approach: a case report and literature review

  • by Zhiqing Zhao, Xinli Sun, Bing Wang, Taiqiang Yan

  • March 18, 2026

Related Content

Colorectal Cancer Treatment During Pregnancy

Colorectal cancer (CRC) impacts about 1 in 13,000 pregnancies in the United States. This article follows the case of a 36-year-old woman diagnosed with CRC while pregnant and highlights considerations around CRC diagnosis and cancer treatment during pregnancy.

Emergency colorectal cancer in old and very elderly patients: a narrative review

Convergent mitochondrial toxicity of fluorinated agents in oncological anaesthesia: sevoflurane, 5-fluorouracil, and the ACOD1/itaconate immune axis